Connection
Amy Amara to Parkinson Disease
This is a "connection" page, showing publications Amy Amara has written about Parkinson Disease.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
10.586 |
|
|
|
-
Amara AW, Catiul C, Videnovic A. Let there be light for Parkinson's disease... but only at the right time. Sleep. 2024 08 14; 47(8).
Score: 0.589
-
Wood KH, Nenert R, Miften AM, Kent GW, Sleyster M, Memon RA, Joop A, Pilkington J, Memon AA, Wilson RN, Catiul C, Szaflarski J, Amara AW. Diffusion Tensor Imaging-Along the Perivascular-Space Index Is Associated with Disease Progression in Parkinson's Disease. Mov Disord. 2024 Sep; 39(9):1504-1513.
Score: 0.585
-
Feuerstein JS, Amara A. REM Behavior Disorder: Implications for PD Therapeutics. Curr Neurol Neurosci Rep. 2023 11; 23(11):727-734.
Score: 0.555
-
Memon AA, Catiul C, Irwin Z, Pilkington J, Memon RA, Joop A, Wood KH, Cutter G, Miocinovic S, Amara AW. Quantitative Sleep Electroencephalogram in Parkinson's Disease: A Case-Control Study. J Parkinsons Dis. 2023; 13(3):351-365.
Score: 0.526
-
Shaban M, Amara AW. Resting-state electroencephalography based deep-learning for the detection of Parkinson's disease. PLoS One. 2022; 17(2):e0263159.
Score: 0.496
-
Srivastava H, Joop A, Memon RA, Pilkington J, Wood KH, Natelson Love M, Amara AW. Taking the Time to Assess Cognition in Parkinson's Disease: The Clock Drawing Test. J Parkinsons Dis. 2022; 12(2):713-722.
Score: 0.491
-
Wood KH, Memon AA, Memon RA, Joop A, Pilkington J, Catiul C, Gerstenecker A, Triebel K, Cutter G, Bamman MM, Miocinovic S, Amara AW. Slow Wave Sleep and EEG Delta Spectral Power are Associated with Cognitive Function in Parkinson's Disease. J Parkinsons Dis. 2021; 11(2):703-714.
Score: 0.458
-
Amara AW. Sleep and cognition in Parkinson's disease. Sleep Med. 2020 09; 73:179-180.
Score: 0.445
-
Amara AW, Wood KH, Joop A, Memon RA, Pilkington J, Tuggle SC, Reams J, Barrett MJ, Edwards DA, Weltman AL, Hurt CP, Cutter G, Bamman MM. Reply to: Exercise for "Sleep Rehabilitation" in Parkinson's Disease. Mov Disord. 2020 07; 35(7):1286.
Score: 0.442
-
Amara AW, Wood KH, Joop A, Memon RA, Pilkington J, Tuggle SC, Reams J, Barrett MJ, Edwards DA, Weltman AL, Hurt CP, Cutter G, Bamman MM. Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's Disease. Mov Disord. 2020 06; 35(6):947-958.
Score: 0.432
-
Cederberg KL, Brinkley EB, Belotserkovkaya N, Memon RA, Motl RW, Amara AW. Does restless legs syndrome impact cognitive function via sleep quality in adults with Parkinson's disease? Int J Neurosci. 2020 Apr; 130(4):322-329.
Score: 0.422
-
Amara AW, Chahine L, Seedorff N, Caspell-Garcia CJ, Coffey C, Simuni T. Self-reported physical activity levels and clinical progression in early Parkinson's disease. Parkinsonism Relat Disord. 2019 04; 61:118-125.
Score: 0.397
-
Amara AW, Memon AA. Effects of Exercise on Non-motor Symptoms in Parkinson's Disease. Clin Ther. 2018 01; 40(1):8-15.
Score: 0.370
-
Ford KJ, Joop A, Memon RA, Wood KH, Ball K, Cutter GR, Schwebel DC, Amara AW. Pedestrian safety in patients with Parkinson's disease: A case-control study. Mov Disord. 2017 Dec; 32(12):1748-1755.
Score: 0.366
-
Amara AW, Chahine LM, Caspell-Garcia C, Long JD, Coffey C, Högl B, Videnovic A, Iranzo A, Mayer G, Foldvary-Schaefer N, Postuma R, Oertel W, Lasch S, Marek K, Simuni T. Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease. J Neurol Neurosurg Psychiatry. 2017 08; 88(8):653-662.
Score: 0.357
-
Birchall EL, Walker HC, Cutter G, Guthrie S, Joop A, Memon RA, Watts RL, Standaert DG, Amara AW. The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease. Brain Stimul. 2017 May - Jun; 10(3):651-656.
Score: 0.347
-
Amara AW, Standaert DG. Metabolomics and the search for biomarkers in Parkinson's disease. Mov Disord. 2013 Oct; 28(12):1620-1.
Score: 0.276
-
Amara AW, Standaert DG, Guthrie S, Cutter G, Watts RL, Walker HC. Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson's disease. Parkinsonism Relat Disord. 2012 Jan; 18(1):63-8.
Score: 0.240
-
Videnovic A, Coffey CS, Klerman EB, Cudkowicz M, Cho HJ, Amara A, Marder K, Zee P, Desir C, Ernst H, Steinhart E, Costigan M, Gudjonsdottir A, Klingner E, Ecklund D, Chase M, Wang A, Charles D, Clifford D, Coleman J, Espay AJ, Hung AY, Kadimi S, Killoran A, Luo L, Malkani R, Margolesky J, Marsella J, Maurer C, Mihaila D, Moretti P, Park A, Phielipp N, Sarva H, Shah B, Shill HA, Siderowf A, Suski V, Tate J, Tse W, Wyant K, Zhang L, Annis C, Ambrogi K, Auerbach G, Benge M, Blystone E, Brenner L, Aguilar CB, Bwala G, Dorsch J, Goude E, Gutierrez H, Harper K, Hochberger S, Kalyani P, Lamb J, Maupin K, Molloy A, Mosovsky S, Sissine M, Steele J, Szela M, Teshome M, Wencel M, Macklin EA. ENLITE PD: A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's Disease. Mov Disord. 2025 Nov; 40(11):2445-2456.
Score: 0.158
-
Baumgartner AJ, Hirt L, Amara AW, Kern DS, Thompson JA. Diurnal fluctuations of subthalamic nucleus local field potentials follow naturalistic sleep-wake behavior in Parkinson's disease. Sleep. 2025 Jun 13; 48(6).
Score: 0.156
-
Anderson KE, Marras C, Amara A, Chahine LM, Eberly S, Hosamath A, Kinel D, Mantri S, Mathur S, Oakes D, Purks JL, Standaert DG, Weintraub D, Shoulson I, Arbatti L. What Parkinson's disease patients say in their own words about their mood and anxiety symptoms. Parkinsonism Relat Disord. 2025 Jan; 130:107190.
Score: 0.150
-
Weintraub D, Marras C, Amara A, Anderson KE, Chahine LM, Eberly S, Hosamath A, Kinel D, Mantri S, Mathur S, Oakes D, Purks JL, Standaert DG, Shoulson I, Arbatti L. Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease. Mov Disord. 2024 Apr; 39(4):706-714.
Score: 0.142
-
Cristini J, Potvin-Desrochers A, Seo F, Dagher A, Postuma RB, Rosa-Neto P, Carrier J, Amara AW, Steib S, Paquette C, Roig M. The Effect of Different Types of Exercise on Sleep Quality and Architecture in Parkinson Disease: A Single-Blinded Randomized Clinical Trial Protocol. Phys Ther. 2024 Jan 01; 104(1).
Score: 0.141
-
Mantri S, Purks JL, Kinel D, Arbatti L, Hosamath A, Allen A, Amara A, Anderson K, Chahine LM, Eberly S, Mathur S, Standaert D, Oakes D, Weintraub D, Shoulson I, Marras C. In Their Own Words: Fears Expressed by People with Parkinson's Disease in an Online Symptom Database. J Parkinsons Dis. 2024; 14(4):865-872.
Score: 0.141
-
Parajuli M, Amara AW, Shaban M. Deep-learning detection of mild cognitive impairment from sleep electroencephalography for patients with Parkinson's disease. PLoS One. 2023; 18(8):e0286506.
Score: 0.137
-
Yacoubian TA, Fang YD, Gerstenecker A, Amara A, Stover N, Ruffrage L, Collette C, Kennedy R, Zhang Y, Hong H, Qin H, McConathy J, Benveniste EN, Standaert DG. Brain and Systemic Inflammation in De Novo Parkinson's Disease. Mov Disord. 2023 05; 38(5):743-754.
Score: 0.133
-
Marras C, Arbatti L, Hosamath A, Amara A, Anderson KE, Chahine LM, Eberly S, Kinel D, Mantri S, Mathur S, Oakes D, Purks JL, Standaert DG, Tanner CM, Weintraub D, Shoulson I. What Patients Say: Large-Scale Analyses of Replies to the Parkinson's Disease Patient Report of Problems (PD-PROP). J Parkinsons Dis. 2023; 13(5):757-767.
Score: 0.132
-
Williams GP, Muskat K, Frazier A, Xu Y, Mateus J, Grifoni A, da Silva Antunes R, Weiskopf D, Amara AW, Standaert DG, Goldman JG, Litvan I, Alcalay RN, Sulzer D, Lindestam Arlehamn CS, Sette A. Unaltered T cell responses to common antigens in individuals with Parkinson's disease. J Neurol Sci. 2023 01 15; 444:120510.
Score: 0.131
-
Picillo M, LaFontant DE, Bressman S, Caspell-Garcia C, Coffey C, Cho HR, Burghardt EL, Dahodwala N, Saunders-Pullman R, Tanner CM, Amara AW. Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson's Disease. J Parkinsons Dis. 2022; 12(1):421-436.
Score: 0.123
-
Videnovic A, Amara AW, Comella C, Schweitzer PK, Emsellem H, Liu K, Sterkel AL, Gottwald MD, Steinerman JR, Jochelson P, Zomorodi K, Hauser RA. Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial. Mov Disord. 2021 10; 36(10):2408-2412.
Score: 0.119
-
Singhania A, Pham J, Dhanwani R, Frazier A, Rezende Dutra J, Marder KS, Phillips E, Mallal S, Amara AW, Standaert DG, Sulzer D, Peters B, Sette A, Lindestam Arlehamn CS. The TCR repertoire of a-synuclein-specific T cells in Parkinson's disease is surprisingly diverse. Sci Rep. 2021 01 11; 11(1):302.
Score: 0.115
-
Cristini J, Weiss M, De Las Heras B, Medina-Rincón A, Dagher A, Postuma RB, Huber R, Doyon J, Rosa-Neto P, Carrier J, Amara AW, Roig M. The effects of exercise on sleep quality in persons with Parkinson's disease: A systematic review with meta-analysis. Sleep Med Rev. 2021 02; 55:101384.
Score: 0.112
-
Lindestam Arlehamn CS, Dhanwani R, Pham J, Kuan R, Frazier A, Rezende Dutra J, Phillips E, Mallal S, Roederer M, Marder KS, Amara AW, Standaert DG, Goldman JG, Litvan I, Peters B, Sulzer D, Sette A. a-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease. Nat Commun. 2020 04 20; 11(1):1875.
Score: 0.109
-
Memon AA, Coleman JJ, Amara AW. Effects of exercise on sleep in neurodegenerative disease. Neurobiol Dis. 2020 07; 140:104859.
Score: 0.109
-
Luo L, Andrews H, Alcalay RN, Poyraz FC, Boehme AK, Goldman JG, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Sutherland M, Kopil C, Naito A, Kang UJ. Motor phenotype classification in moderate to advanced PD in BioFIND study. Parkinsonism Relat Disord. 2019 08; 65:178-183.
Score: 0.103
-
Kelly NA, Wood KH, Allendorfer JB, Ford MP, Bickel CS, Marstrander J, Amara AW, Anthony T, Bamman MM, Skidmore FM. High-Intensity Exercise Acutely Increases Substantia Nigra and Prefrontal Brain Activity in Parkinson's Disease. Med Sci Monit. 2017 Dec 23; 23:6064-6071.
Score: 0.093
-
Goldman JG, Andrews H, Amara A, Naito A, Alcalay RN, Shaw LM, Taylor P, Xie T, Tuite P, Henchcliffe C, Hogarth P, Frank S, Saint-Hilaire MH, Frasier M, Arnedo V, Reimer AN, Sutherland M, Swanson-Fischer C, Gwinn K, Kang UJ. Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features. Mov Disord. 2018 02; 33(2):282-288.
Score: 0.093
-
Chahine LM, Amara AW, Videnovic A. A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015. Sleep Med Rev. 2017 10; 35:33-50.
Score: 0.085
-
Kang UJ, Goldman JG, Alcalay RN, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Rudolph A, Casaceli C, Andrews H, Gwinn K, Sutherland M, Kopil C, Vincent L, Frasier M. The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort. Mov Disord. 2016 06; 31(6):924-32.
Score: 0.083
-
Chahine LM, Xie SX, Simuni T, Tran B, Postuma R, Amara A, Oertel WH, Iranzo A, Scordia C, Fullard M, Linder C, Purri R, Darin A, Rennert L, Videnovic A, Del Riva P, Weintraub D. Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder. Parkinsonism Relat Disord. 2016 06; 27:102-6.
Score: 0.082
-
Simuni T, Caspell-Garcia C, Coffey C, Chahine LM, Lasch S, Oertel WH, Mayer G, Högl B, Postuma R, Videnovic A, Amara AW, Marek K. Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study. Mov Disord. 2015 Sep; 30(10):1371-81.
Score: 0.078
-
Sung VW, Watts RL, Schrandt CJ, Guthrie S, Wang D, Amara AW, Guthrie BL, Walker HC. The relationship between clinical phenotype and early staged bilateral deep brain stimulation in Parkinson disease. J Neurosurg. 2013 Dec; 119(6):1530-6.
Score: 0.069
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|